Reviva Pharmaceuticals Holdings, Inc. RVPH
0.48
(0.04)
(7.69%)
as of 25 Sep
- Market cap
- $5.0M
- P/E
- 0.0×
Follow RVPH
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Jan '22 | Dec '21 | Jan '21 | Dec '20 | Feb '20 | Jan '20 | |
|---|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
2.08 | 1.01 | 1.38 | 1.90 | 3.13 | 13.39 | 13.39 | 6.57 | 0.46 | 6.57 |
Net Debt/EBITDA |
0.71 | 0.44 | 0.59 | 0.66 | 0.76 | 2.94 | 2.94 | 3.60 | (0.94) | 3.60 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1.23% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.15 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
1.24 | 1.12 | 0.72 | 0.67 | 0.78 | 1.25 | 1.25 | 1.07 | (0.69) | 0.98 |
Capex/Depreciation |
— | — | — | — | — | — | — | 0.00 | — | 0.00 |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (419.97%) | (916.17%) | (556.38%) | (272.92%) | (118.72%) | (29.71%) | (49.91%) | (72.30%) | 9.94% | 26.60% | |
| (126.42%) | (152.63%) | (184.22%) | (149.34%) | (96.72%) | (27.14%) | (42.43%) | (10.84%) | 1.77% | (86.33%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (7.97%) | 0.00% |
Return on Tangible Assets |
(253.77%) | (36,530.89%) | (601.66%) | (315.36%) | (188.91%) | (29.33%) | (29.33%) | (50.92%) | (384.27%) | (50.94%) |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | — | 0.00% | — | 0.00% | — | — |
Free Cash Flow per Share |
(6.78) | (19.88) | (23.80) | (19.43) | (0.97) | (14.42) | (0.72) | (26.56) | (3.27) | (1.22) |
Cash per Share |
3.98 | 7.99 | 19.64 | 18.98 | 0.95 | 40.14 | 2.01 | 57.22 | 0.53 | 2.86 |
Shareholders Equity per Share |
2.38 | 0.48 | 4.81 | 8.60 | 0.63 | 38.79 | 1.94 | 35.70 | 38.31 | 2.43 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
2.38 | 0.48 | 4.81 | 8.60 | 0.63 | 38.79 | 1.94 | 35.70 | 38.31 | 2.43 |
Free Cash Flow |
(24.59) | (33.54) | (28.32) | (18.96) | (18.96) | (10.67) | (10.67) | (4.07) | (0.43) | (3.73) |
Working Capital |
7.83 | 0.08 | 6.53 | 8.96 | 12.88 | 29.06 | 29.06 | 7.43 | (0.16) | 7.43 |
Net Current Asset Value |
7.83 | (0.01) | 5.72 | 8.39 | 12.32 | 28.69 | 28.69 | 5.47 | (55.88) | 7.43 |
| Other line items | ||||||||||
Quick Ratio |
1.98 | 0.92 | 1.36 | 1.86 | 3.07 | 12.66 | 12.66 | 6.57 | 0.23 | 6.57 |
Depreciation/Fixed assets |
— | — | — | — | — | — | — | 0.00 | — | 0.00 |
Cash ROIC |
(106.53%) | (234.75%) | (97.38%) | (70.45%) | (61.49%) | (18.28%) | (18.28%) | (28.59%) | (7.33%) | (23.01%) |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | — | — | — | — | — | — | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | — | — | — | — | — | — | 0.00 |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(6.78) | (19.88) | (23.80) | (19.43) | (0.97) | (14.42) | (0.72) | (26.56) | (3.27) | (1.22) |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Payables |
4.65 | 5.07 | 3.68 | 3.52 | 2.01 | 0.51 | 0.76 | 0.65 | 0.26 | — |
Average Assets |
15.71 | 19.60 | 21.31 | 18.92 | 25.16 | 31.40 | 20.08 | 34.89 | 34.89 | 4.38 |
Average Common Equity |
4.73 | 3.27 | 7.06 | 10.36 | 20.50 | 28.69 | 17.08 | 5.23 | 6.21 | (14.23) |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates